1. Home
  2. KVYO vs PTCT Comparison

KVYO vs PTCT Comparison

Compare KVYO & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Klaviyo Inc. Series A

KVYO

Klaviyo Inc. Series A

HOLD

Current Price

$18.61

Market Cap

5.3B

Sector

N/A

ML Signal

HOLD

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

HOLD

Current Price

$69.30

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KVYO
PTCT
Founded
2012
1998
Country
United States
United States
Employees
2368
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.3B
6.0B
IPO Year
2023
2006

Fundamental Metrics

Financial Performance
Metric
KVYO
PTCT
Price
$18.61
$69.30
Analyst Decision
Strong Buy
Buy
Analyst Count
21
17
Target Price
$34.48
$80.65
AVG Volume (30 Days)
5.6M
735.7K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
35.29
264.48
EPS
N/A
0.90
Revenue
$1,234,019,000.00
$264,734,000.00
Revenue This Year
$24.47
N/A
Revenue Next Year
$19.66
$17.70
P/E Ratio
$657.67
$77.00
Revenue Growth
31.63
36.19
52 Week Low
$12.53
$57.74
52 Week High
$36.23
$90.87

Technical Indicators

Market Signals
Indicator
KVYO
PTCT
Relative Strength Index (RSI) 58.19 45.92
Support Level $15.67 $67.57
Resistance Level $21.74 $73.86
Average True Range (ATR) 0.92 2.00
MACD 0.15 0.17
Stochastic Oscillator 76.02 54.08

Price Performance

Historical Comparison
KVYO
PTCT

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: